USE OF AT LEAST TWO ANTICANCER COMPOUNDS, ONE OF WHICH AT LEAST MODULATES PROTEASOME ACTIVITY FOR MAKING A MEDICINE FOR CANCER TREATMENT

Details for Australian Patent Application No. 2003263263 (hide)

International Classifications

Event Publications

11 December 2003 Complete Application Filed

Priority application(s): 02/08458 05.07.02 FR

11 March 2004 Application Open to Public Inspection

Published as AU-A-2003263263

2 June 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

25 August 2005 Corrigenda

Applications OPI - Name Index Under the name BIOMERIEUX, Application No. 2003263263, under INID (71) correct the name to read INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE I.N.S.E.R.M.; BIOMERIEUX

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.